KRT19 and cirrhosis of liver: When liver cirrhosis occurs, hypoxia‐induced growth factors can promote intrahepatic bile duct hyperplasia, the CK19‐labeled intrahepatic bile duct can indirectly reflect the degree of liver cirrhosis, and BMSCs treatment can inhibit intrahepatic bile duct hyperplasia (Figure S2A, Supporting Information).